Los puntos clave no están disponibles para este artículo en este momento.
The use of composite end points in cardiovascular trials is frequently complicated by large gradients in importance to patients and in magnitude of the effect of treatment across component end points. Higher event rates and larger treatment effects associated with less important components may result in misleading impressions of the impact of treatment.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ignacio Ferreira‐González
Cardiac Imaging
Gaiet Permanyer-Miralda
Antònia Domingo‐Salvany
St. Alexius Heart and Lung Clinic
BMJ
Mayo Clinic
McMaster University
Western University
Building similarity graph...
Analyzing shared references across papers
Loading...
Ferreira‐González et al. (Mon,) studied this question.
synapsesocial.com/papers/69cc63422893a4923719c80d — DOI: https://doi.org/10.1136/bmj.39136.682083.ae
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: